Axcap Ventures Inc.
GARLF
$0.125
-$0.0171-12.03%
| Weiss Ratings | GARLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | GARLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | GARLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.04 | |||
| Price History | GARLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 3.65% | |||
| 30-Day Total Return | -16.67% | |||
| 60-Day Total Return | -11.10% | |||
| 90-Day Total Return | -21.48% | |||
| Year to Date Total Return | -11.60% | |||
| 1-Year Total Return | 160.96% | |||
| 2-Year Total Return | 0.00% | |||
| 3-Year Total Return | -72.58% | |||
| 5-Year Total Return | -66.14% | |||
| 52-Week High % Change | -60.99% | |||
| 52-Week Low % Change | 330.07% | |||
| Price | GARLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.36 | |||
| 52-Week Low Price | $0.03 | |||
| 52-Week Low Price (Date) | May 22, 2024 | |||
| 52-Week High Price (Date) | Oct 30, 2024 | |||
| Valuation | GARLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 25.39M | |||
| Enterprise Value | 24.16M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.17 | |||
| Earnings Per Share Growth | -18.30% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 8.36 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.13 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -20.98 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | GARLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 76.75M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | GARLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 604 687 7130 | |||
| Address | 1090 West Georgia Street Vancouver, BC V6E 3V7 | |||
| Website | axcapventures.com | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | GARLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | GARLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -28.72% | |||
| Return on Equity | -- | |||
| Income Statement | GARLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -1.15M | |||
| Net Income (TTM) | -1.44M | |||
| Net Income Avl. to Common (TTM) | -1.44M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 29.16% | |||
| EPS Diluted (TTM) | -0.17 | |||
| EPS Diluted Growth (Q YOY) | 94.63% | |||
| Balance Sheet | GARLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.31M | |||
| Cash Per Share (Q) | $0.02 | |||
| Total Current Assets (Q) | 2.45M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 3.21M | |||
| Current Ratio (Q) | 3.900 | |||
| Book Value Per Share (Q) | $0.02 | |||
| Total Assets (Q) | 3.84M | |||
| Total Current Liabilities (Q) | 628.40K | |||
| Total Debt (Q) | 0.00 | |||
| Total Liabilities (Q) | 628.40K | |||
| Total Common Equity (Q) | 3.21M | |||
| Cash Flow | GARLF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 93.60K | |||
| Cash from Financing (TTM) | 3.19M | |||
| Net Change in Cash (TTM) | 1.12M | |||
| Levered Free Cash Flow (TTM) | -1.10M | |||
| Cash from Operations (TTM) | -2.16M | |||
